Background. Ex vivo lung perfusion (EVLP) has the potential to increase the number of
donor lungs available for lung transplantation (LTx). While the current maximum cold …

Background Ex vivo lung perfusion (EVLP) has developed as the most effective technique
for estimating marginal donor lungs. This study attempted to extend the EVLP running time …

Background Ex vivo lung perfusion (EVLP) was primarily developed for evaluation of
impaired donor lungs. The good clinical results raise the question for its possible impact on …

Background More than 80% of donor lungs are potentially injured and therefore not
considered suitable for transplantation. With the use of normothermic ex vivo lung perfusion …

Background Ex vivo lung perfusion (EVLP) allows normothermic evaluation and treatment of
donor lungs not currently acceptable for transplant and improves organ use. Donor lungs …

Purpose lung transplantation continues to be a life saving therapy for patients with end stage
lung disease. In a donor restrictive environment and with only 22% of donor lungs currently …

Purpose Expected Completion Date: March 2009. Sponsor of the trial: VITROLIFE. Summary
of Objectives: 1) To examine the feasibility and safety of ex vivo perfusion of extended …

Purpose Normothermic ex vivo lung perfusion (EVLP) is a method to evaluate and improve
function of injured donor lungs. We reviewed 3-center experience using the previously …

Normothermic ex vivo lung perfusion (EVLP) has developed as a powerful technique to
evaluate particularly marginal donor lungs prior to transplantation. In this study, acellular …

Purpose Ex vivo lung perfusion (EVLP) allows re-evaluation of extended criteria/marginal
donor lungs. This can increase the number of lung transplants. However, the long-term …